Integrated 3D-QSAR and Molecular Modeling of Tetrazanbigen Derivatives: Insights into Cellular Antiproliferative Activity and PPARγ Interactions
Year: 2026
Type: article
Abstract: In this study, CoMFA and CoMSIA models were developed using the reported antiproliferative activities of 34 tetrazanbigen derivatives against LoVo cancer cells. The models were used to investigate structure–activity relationships and to guide the design of six new analogs (P1–P6). Density functional theory calculations, molecular docking, molecular dynamics simulations, and MM/GBSA analyses were subsequently employed to characterize molecular properties and explore the predicted interactions of selected compounds with the PPARγ ligand-binding domain. Importantly, the QSAR models describe cellular antiproliferative activity rather than direct receptor-binding affinity or functional PPARγ activation. Likewise, the structure-based calculations provide computational hypotheses about ligand–receptor interactions but do not establish agonist efficacy or partial agonism. The proposed analogues therefore require experimental evaluation of both antiproliferative activity and PPARγ binding and transactivation before their biological profiles can be established.
Authors: Abderrafie Drajou, Oussama Chedadi(Methodology, Validation), Abdeslam Dakhama(Validation, Writing – original draft), Hajar El Ouarti(Data curation, Validation), Kamal Laourdani(Formal analysis), Abdelilah Toughzaoui(Resources, Supervision), Lamy M. M. Hamed(Resources, Supervision), Khalil Azzaoui(Data curation, Validation), Hammouti Belkheir(Resources, Supervision), Ahmed El-Harairy(Conceptualization, Project administration, Supervision, Writing – review & editing), Abdelkrim Ouammou(Supervision, Validation, Writing – review & editing), Kamal Moradi(Conceptualization, Project administration, Supervision, Writing – review & editing)
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7236810223
